The Doctor’s Advocate | Third Quarter 2024
Foundation News

Spotlight on Grants: Identifying and Mitigating Patient Safety Risks Associated With Telehealth Referrals

The Doctors Company Foundation supported a project by the MedStar Health National Center for Human Factors in Healthcare, one of the largest human factors programs embedded within a U.S. healthcare system, to develop an assessment tool to identify and mitigate the patient safety risks associated with referrals from telehealth to in-person care.

Through interviews with patients and providers and feedback from subject matter experts, the project team identified specific risks associated with the on-demand referral process. From these results, the team developed a comprehensive guide and risk assessment tool that enable healthcare systems to evaluate telehealth referral safety and identify areas for improvement.

Learn more about this project and how the Foundation funds patient safety research, education, and training.


The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.